GLOBAL RESEARCH ARCHIVE
PT Avia Avian "Oversold on oil concerns" (Buy) Chew
Research evidence excerpt
PT Avia Avian "Oversold on oil concerns" (Buy) Chew
s.
movements. Recognizing the fluidity of the disruption in the Middle East and its impact 12/26E 33 28 -16 27
on global oil prices, we test AVIA's earnings sensitivity against UBS's Global Oil team's 12/27E 35 32 -9 32
four price scenarios. Under the base case (~US$86/bbl), we estimate earnings growth 12/28E 38 34 -9 34
deceleration of -2% and expect margins to recover from 2027E, while even at elevated
levels (~US$100/bbl), earnings downside is contained at -10%, with only a more Bernice Chew
extreme stress case (~US$132.5/bbl) implying -30% downside. In addition, AVIA retains Analyst
bernice.chew@ubs.com
additional earnings levers through discretionary A&P spend, supporting margin
+65-6495 3507
resilience and recovery beyond cost normalization.
Permada Darmono
Government initiatives and capital flexibility could provide mid-term upside Analyst
permada.darmono@ubs.com
Beyond cyclical factors, we believe AVIA offers underappreciated medium-term growth +65-6495 3137
optionality. Indirect exposure to government initiatives such as the 3 million Housing
Program could drive ~1ppt volume growth, with 6–8% potential upside as execution
scales, while rural programs (Kopdes) could support further penetration. Coupled with a
strong balance sheet (Rp1.7trn cash on hand and 0.16x net D/E) and robust FCF
generation (Rp1.3-1.8trn over 2026-28E), we believe AVIA has clear capacity for bolt-on
M&A in adjacencies such as adhesives and construction chemicals.
Valuation: DCF-based price target of Rp500 (from Rp840); resume at Buy
Trading at 13x forward PE (c.20% discount to global peers despite higher growth and
returns), we see compelling value with clear catalysts for a potential re-rating.
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer